OWC PHARMACEUTICAL RESEARCH CORP. *Cannabis Research for Treatments*
Based in Israel Ticker [OTC : OWCP]
Overview
OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development of cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, PTSD, migraines, and of a unique delivery system.
Dr. Ben-Zion Weiner of TEVA was among the original investors in OWCP, and is advising the Company. Dr. Ben-Zion Weiner was Head of Global Research and Development at Teva Pharmaceutical Industries Ltd. for over three decades, including as Chief R&D Officer and as a member of the Teva Executive Committee.
Industry Articles
Cannabis Expert Jeffrey Friedland on Cannabis / Israel and OWCP http://www.jeffreyfriedland.com/single-post/2016/11/07/Tuesday%E2%80%99s-
Marijuana Company Prepares to Cross State Lines http://www.nytimes.com/2016/11/10/business/smallbusiness/marijuana-company-prepares-to-cross-state-lines-as-legally-as-possible.html?_r=0
Trump is going to be great for medical marijuana and each state can take it from there. His administration is not going to bother the states.
That is real American thought. States rights, especially on an issue like this. George Washington and Thomas Jefferson both grew hemp as a cash crop to make rope and clothes. Now we know of many other uses including medical.